ARTICLE | Management Tracks
Senti Bio, Sangamo alum Lee joins Lyell as CSO
Plus Leaming and Posner retire from Biogen’s board, Bourdon moves to Leo, and updates from Keros, NeoTX and more
February 1, 2022 1:05 AM UTC
T-cell programming company Lyell Immunopharma Inc. (NASDAQ:LYEL) hired Gary Lee as CSO. Lee was CSO at Senti Biosciences Inc. and held several roles at Sangamo Therapeutics Inc. (NASDAQ:SGMO) for 13 years, including as VP of cell therapy. Additionally, Nick Restifo, the EVP of research at the company, will transition to the role of scientific adviser on Feb. 15.
Nancy Leaming, a member of the audit committee, and Brian Posner, the chairman of the compensation management and development committee, will retire from the board at Biogen Inc. (NASDAQ:BIIB), effective at the 2022 annual meeting of stockholders. Leaming and Posner both joined the company’s board in 2008. ...